Eric Geijteman

Dr. Eric Geijteman is a researcher in the Department of Medical Oncology at Erasmus MC, Rotterdam. His work focuses on pharmacological interventions in cancer care, particularly anticoagulant management and pain therapy optimization.

• Institution: Erasmus MC
• Department: Medical Oncology
• Academic Role: Researcher

Research interests include anticoagulant therapy, thromboembolic risk, pharmacokinetics, and end-of-life care. He specializes in validating drug exposure models and optimizing analgesic regimens in palliative oncology.

Recent publications analyze anticoagulant discontinuation safety, cross-national cohort survival metrics, and fentanyl administration transitions. Key trends involve bleeding risk, cohort analysis, and cardiovascular complications in advanced cancer patients.

Collaborations span 11 countries, including Denmark, Netherlands, and international consortia like SERENITY and iLIVE.